Pulmonary hypertension Historical Perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 18: | Line 18: | ||
* In 1973, '''''1st WHO Meeting on pulmonary hypertension''''' the landmark meeting about pulmonary hypertension, provided recommendations for future directions. | * In 1973, '''''1st WHO Meeting on pulmonary hypertension''''' the landmark meeting about pulmonary hypertension, provided recommendations for future directions. | ||
* In 1981, pulmonary hypertension registry landmark multi-center U.S. study characterizing natural history and clinical features of primary pulmonary hypertension (PPH). | * In 1981, pulmonary hypertension registry landmark multi-center U.S. study characterizing natural history and clinical features of primary pulmonary hypertension (PPH). | ||
* In 1998, '''''2nd World Symposium on pulmonary hypertension,''''' formation of Evian Classification of pulmonary hypertension and the term pulmonary arterial hypertension (PAH) was coined. | |||
* In 1998 '''''2nd World Symposium on pulmonary hypertension,''''' formation of Evian Classification of pulmonary hypertension and the term pulmonary arterial hypertension (PAH) was coined. | * In 2003, '''''3rd World Symposium on pulmonary hypertension,''''' formation of Venice Classification; idiopathic PAH introduced to replace term PPH. | ||
* In 2003 '''''3rd World Symposium on pulmonary hypertension,''''' formation of Venice Classification; idiopathic PAH introduced to replace term PPH. | * In 2008, '''''4th World Symposium on pulmonary hypertension,''''' formation of Dana Point Classification; modification of genetic category, among others in Group 1. | ||
* In 2008 '''''4th World Symposium on pulmonary hypertension,''''' formation of Dana Point Classification; modification of genetic category, among others in Group 1. | * In 2013, '''''5th World Symposium on pulmonary hypertension,''''' formation of Nice Classification; further modifications of genetic category, among others in Group 1. | ||
* In 2013 '''''5th World Symposium on pulmonary hypertension,''''' formation of Nice Classification; further modifications of genetic category, among others in Group 1. | * In 2014, '''''International Right Heart Failure Foundation''''' - comprehensive nomenclature of RHF ([[right heart failure]]) defining distinction between [[right heart failure]] vs [[Right heart failure|right ventricular failure]] vs components of right heart system, and the definition of [[right heart failure]]. | ||
* In 2014 '''''International Right Heart Failure Foundation''''' - comprehensive nomenclature of RHF ([[right heart failure]]) defining distinction between [[right heart failure]] vs [[Right heart failure|right ventricular failure]] vs components of right heart system, and the definition of [[right heart failure]]. | |||
==References== | ==References== | ||
Revision as of 13:38, 27 March 2018
|
Pulmonary Hypertension Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pulmonary hypertension Historical Perspective On the Web |
|
American Roentgen Ray Society Images of Pulmonary hypertension Historical Perspective |
|
Risk calculators and risk factors for Pulmonary hypertension Historical Perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
In 1891 a German physician Ernst von Romberg described pulmonary vascular sclerosis in an autopsy. In 1951 David Dresdale coined the term primary pulmonary hypertension for the first time.
Historical Perspective
- The Historical Perspective of the PH is as follows:[1][2]
- In 1891, a German physician Ernst von Romberg described pulmonary vascular sclerosis in an autopsy.
- In 1901, Abel Ayerza Key lecture integrating cyanosis and right heart failure, named the condition as cardiac negro - black heart.
- In 1913, F. C. Arrillaga, assigned syphilitic arteriosclerosis as etiology of PH; changed the name of disease to Ayerza’s Disease.
- In 1929, Werner Forssman demonstrated that it was possible to perform right sided catheterization in humans by performing catheterization on himself.
- In 1951, David Dresdale coined the term primary pulmonary hypertension for the first time.
- In 1956, Forssman, Cournand, and Richards were awarded the Nobel Prize for their contributions to the discovery of circulatory and cardiopulmonary systems.
- In 1958, Paul Wood published pulmonary hypertension with an association with a vasoconstrictive factor.
- During 1965–1970s, first pulmonary hypertension epidemic related to the approval of Aminorex.
- In 1973, 1st WHO Meeting on pulmonary hypertension the landmark meeting about pulmonary hypertension, provided recommendations for future directions.
- In 1981, pulmonary hypertension registry landmark multi-center U.S. study characterizing natural history and clinical features of primary pulmonary hypertension (PPH).
- In 1998, 2nd World Symposium on pulmonary hypertension, formation of Evian Classification of pulmonary hypertension and the term pulmonary arterial hypertension (PAH) was coined.
- In 2003, 3rd World Symposium on pulmonary hypertension, formation of Venice Classification; idiopathic PAH introduced to replace term PPH.
- In 2008, 4th World Symposium on pulmonary hypertension, formation of Dana Point Classification; modification of genetic category, among others in Group 1.
- In 2013, 5th World Symposium on pulmonary hypertension, formation of Nice Classification; further modifications of genetic category, among others in Group 1.
- In 2014, International Right Heart Failure Foundation - comprehensive nomenclature of RHF (right heart failure) defining distinction between right heart failure vs right ventricular failure vs components of right heart system, and the definition of right heart failure.